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Zinc oxide (ZnO) nanocomposites have been widely applied in biomedical 
fields due to their multifunctionality and biocompatibility. However, the 
physicochemical properties of ZnO nanocomposite involved in nano–bio 
interactions are poorly defined. To assess the potential applicability of ZnO 
nanowires for intracellular delivery of biomolecules, I examined the dynamics 
of cellular activity of cells growing on densely packed ZnO nanowire arrays 
with two different physical conformations, vertical (VNW) or fan-shaped 
(FNW) nanowires. Although a fraction of human embryonic kidney cells 
cultured on VNW or FNW underwent rapid apoptosis, peaking at 6 h after 
incubation, cells could survive and replicate without significant apoptosis on 
the foreign substrate after 12 h of lag phase. In addition, the cells formed 
lamellipodia to wrap FNW, and efficiently took up peptides non-covalently 
coated on VNW and FNW within 30 min of incubation. Moreover, FNW 
could mediate intracellular delivery of associated DNAs and their gene 
expression, suggesting that ZnO nanowires transiently penetrate membranes 
to mediate intra-nuclear delivery of exogenous DNA. These results indicate 
that ZnO nanowire arrays can serve as nanocomposites for manipulating 
nano–biointerfaces if appropriately modified in a 3-dimensional 
conformation. Radially grown ZnO nanowires on poly-L-lactic acid (PLLA) 
microfibers with the unique 3-dimensional structure were also synthesized 
and applied as therapeutic cancer vaccines. This inorganic-organic hybrid 
nanocomposite has mild cellular toxicity but efficiently delivers a tumor 
antigen into dendritic cells, cellular bridges between innate and adaptive 
2 
 
immunity, to stimulate them to express inflammatory cytokines and activation 
surface markers. I also demonstrated that the hybrid nanocomposites 
successfully induce tumor antigen-specific cellular immunity and significantly 
inhibit tumor growth in vivo. ZnO nanowires on PLLA fibers systemically 
reduced immune suppressive Treg cells and enhanced the infiltration of T cells 
into tumor tissues, compared to mice immunized with PLLA fibers coated 
with the antigen. These findings open a new avenue in extending the 
biomedical application of inorganic metal oxide-inert organic hybrid 
nanocomposites as a novel vaccine platform. 
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 5. General Introduction 
Zinc oxide (ZnO) has long been used in our daily life as ingredients of 
medicine, cosmetics, and food additives. Piezoelectric ZnO has also been 
widely applied in optoelectronics, sensors, transducers, energy conversion [1-
3]. ZnO is a metal oxide semiconductor material with a direct wide band gap 
energy (3.37 eV) and a large exciton binding energy (60 meV) at room 
temperature [1].  ZnO crystallize in either cubic zinc-blende or hexagonal 
wurtzite structure where each anion is surrounded by four cations at the 
corners of a tetrahedron, and vice versa. The crystal structures shared 
by ZnO are wurtzite, zinc blende, and rocksalt. The hexagonal wurtzite is the 
most stable phase thermodynamically [1].  Medical application of ZnO has a 
long history. For example, a probable form of ZnO, named as Pushpanjan, for 
eyes and open wound treatment is mentioned in the Indian ancient medical 
textbook, the Charaka Samhita which was written around 500 B.C. [4]. ZnO 
lotion is introduced by a Greek physician, Dioscorides, in the first century 
A.D. Avicenna, a Persian philosopher, and physician, also discussed about 
ZnO in his book, The Canon of Medicine, as a preferred cure for a multiple 
skin diseases, including skin cancer [4]. ZnO has been produced by heating 
zinc ore in a shaft furnace. The liberated metallic zinc as a vapor, which then 
ascended the flue and condensed as the oxide for various applications [5-6]. 
Historic and modern evidences suggest potential applicability of ZnO 
in biomedical sciences. Biodegradability and low toxicity of ZnO 
nanomaterials also underscore the relevance of their biomedical applications 
[2]. ZnO nanocrystals and nanostructures have been employed for the 
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luminescence imaging of cells [7]. RGD peptide-conjugated ZnO exhibiting 
green luminescence demonstrated that the nanowires are useful for 
molecularly targeted imaging of cancer cells [8]. Other studies have shown 
that biomolecule penetration inside the cells can be a useful tool for in-depth 
cytology, modeling, and simulation of gene circuits, as well as antigen 
delivery for immunotherapy [10-11]. However, ZnO nanowires (NWs) have 
been poorly characterized for biomedical application, and there have been 
only a few reports for the use of the biological field [11]. Even though it has 
been shown that zinc has a positive effect on the immune system, [12-14] only 
a few reports have shown the uses of ZnO nanocomposites as immune 
modulator. In a recent study, ZnO nanoparticle was shown to have adjuvant 
potential when combined with vaccine antigen [15]. ZnO also enhances the 
innate immune responses via stimulation of TLR6-mediated signaling [15-
17]. In another report, ZnO nanoparticles have shown to promote antigen 
uptake by dendritic cells [18]. Additionally, ZnO nanoparticles or mesoporous 
ZnO has also shown to have a potent anti-cancer effect [19-21].  
In this study, I have extensively analyzed nano-bio interfaces by using 
ZnO nanowires in various three-dimensional forms and investigated the 
possible correlation of the physical conformation of the 3D structures with 
cytotoxicity and efficacy of intracellular delivery of associated bio-
macromolecules. In addition, I investigated the potential application of ZnO 
nanowires, forming a unique 3D structure on poly-L-lactic acid (PLLA) 
microfibers, a biocompatible organic matrix, as an immunotherapeutic 
adjuvant system for cancer immunotherapy. Radially grown ZnO nanowires 
on PLLA fibers were complexed with a tumor antigen, carcinoembryonic 
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antigen (CEA), to be exploited as a novel intracellular antigen delivery 
system. The immune stimulatory effect of the inorganic-organic hybrid 
nanocomposites was confirmed in vitro using phagocytic dendritic cells. 
Immunization with the CEA-coated hybrid nanocomposites not only enhanced 
antigen-specific T cell responses, but also suppressed tumor growth 
significantly better than PLLA fibers mixed with CEA in an in vivo mouse 
model, demonstrating that incorporation of ZnO nanowires into the inorganic-
organic hybrid composite has promising potential as a vaccine adjuvant for 


















 6. Chapter 1 
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Zinc oxide (ZnO) is a unique material that exhibits exceptional 
semiconducting, piezoelectric, and pyroelectric properties so have therefore 
been widely applied in nano-electronics, optoelectronics, sensors, light-
emitting diodes, photo-catalysis, nano-generators, and nanopiezotronics [1-2]. 
The metal oxide has also been applied in food, UV-blocking agents, and anti-
microbial materials, due to its multi-functionality and biocompatibility. 
ZnO-based nanocomposites have shown promising potential in bio-
imaging, drug delivery, and immunotherapy during the last decade [15, 57, 
18]. Previously, ZnO nanoparticles chemically conjugated with acid-sensitive 
polymers were shown to be taken up by cancer cells through endocytosis, and 
release a preloaded anti-cancer drug into cellular lysosomes in a pH-
dependent manner [34]. It was also reported that an iron oxide–ZnO core-shell 
nanoparticle can efficiently deliver a tumor antigen fused with ZnO-binding 
peptide (ZBP) into dendritic cells and potently enhance antigen-specific 
immunity in vivo when applied for cancer immunotherapy [18]. It appears that 
ZnO nanoparticle itself possesses adjuvant potential as a vaccine carrier when 
combined with an antigen having high affinity to the metal oxide [15].  
In addition to chemical drugs and protein antigens, plasmid DNA can 
also be delivered and expressed in eukaryotic cells when associated with ZnO 
nanostructures [11, 35]. Silica-coated and amino-modified tetrapod-like ZnO 
nanostructures can bind plasmid DNA through electrostatic interactions and 
mediate intracellular delivery and expression of the associated DNA in 
mammalian cells [11]. The unique three dimensional (3D) structure of ZnO 
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tetrapods might be important for the direct delivery of DNA and its gene 
expression in eukaryotic cells since there was no detectable gene expression 
when using silica and DNA coated simple ZnO nanorods [11]. Recently, it 
was also reported that ZnO nanowires conjugated to DNA via disulfide bonds 
could also deliver nucleic acids into rigid algal cells after physical 
pressurization, and result in better gene expression compared to traditional 
bead beating and electroporation [35]. These results indicate that ZnO 
nanostructures can be applied as delivery vehicles for bio-macromolecules, 
such as proteins and DNA, into eukaryotic cells with appropriately modified 
surfaces and 3D structures, or with physical force. However, detailed 
mechanisms of how ZnO nanostructures mediate intracellular delivery of 
associated bio-macromolecules remain elusive. 
In addition, ZnO nanocomposites are known to exert cytotoxicity 
depending on their size, shape, surface modification, and concentration [21-
24, 36-37]. The effect of 3D structure on biological systems has been poorly 
defined, and most studies use spherical ZnO nanoparticles, which are readily 
internalized into cells by endocytosis or phagocytosis [18, 36]. The cytotoxic 
potential of ZnO nanoparticles is generally attributed to dissolution of the 
metal oxide complex into Zn2+ ions, especially in acidic environments such as 
lysosomes [38]. Cellular uptake of ZnO nanoparticles may facilitate an 
increase in intracellular Zn2+, leading to rapid perturbation of cellular Zn2+ 
homeostasis, which ultimately induces reactive oxygen species (ROS) 
generation, DNA damage, and apoptotic cell death [36].  Previously, it was 
shown that the toxic potency of ZnO tetrapods in the nano-micron size range 
is significantly lower than that of spherical ZnO nanoparticles, [39, 40] 
15 
 
indicating that physical constraints of 3D structure may limit the intracellular 
uptake of the complex so that less Zn2+ ions are generated, thereby reducing 
cellular toxicity. Nevertheless, direct contact of ZnO nanowires in the 
tetrapods with cells, induced a degree of cellular toxicity, potentially due to 
local generation of Zn2+ or physical damage [39-41]. Therefore, the primary 
factors of ZnO nanocomposite that induce biological toxicity as well as 
influence the efficacy of intracellular delivery of associated bio-
macromolecules need to be further defined to improve their biological 
applicability.  
In this study, densely packed ZnO nanowire arrays with two different 
physical arrangements, vertical and fan-shaped forms, synthesized by a 
hydrothermal method [41] were used for biological application, especially for 
intracellular delivery of bio-macromolecules. I investigated the possible 
correlation of the physical conformation of the 3D structures with cytotoxicity 










6.2. Material Methods 
 
6.2.1. Synthesis of ZnO nanowire 
ZnO nanomaterials were synthesized as follows and supplied by Professor 
Young Keun Kim’s laboratory, Korea University. The ZnO nanoparticles, 
which act as seeds were synthesized using 50 mM Zn(NO3)•6H2O, 12 mM 
cetyltrimethylammonium bromide (CTAB) in ethanol and an equivalent 
volume of 0.1 M NaOH in ethanol. This solution was washed with ethyl 
alcohol using an ultrasonic cleaner and centrifuged after vigorous stirring for 
one hour to precipitate the ZnO nanoparticles [42]. Two types of ZnO 
nanowire arrays were synthesized by a hydrothermal method. A ZnO thin 
layer and ZnO nanoparticles were used as seed layers. The cover glasses were 
cleaned by sonication in acetone, ethyl alcohol, and deionized water. ZnO 
layer (100 nm), Seed layers were deposited on the substrates by a dc 
magnetron sputtering system. ZnO nanoparticles which were suspended in the 
diluted solution (10 µg/ml) were dropped over the substrates. A 10 mM of 
zinc nitrate hexahydrate (Zn(NO3)•6H2O), and 10 mM of 
hexamethylenetetramine (HMTA, C6H12N4) were dissolved in deionized water 
to synthesize the ZnO nanowire arrays on the seeded cover glass. 
Additionally, 2 mM of polyethyleneimine (PEI, branched, low molecular 
weight, Aldrich) and 6 mM of ammonium chloride (NH4Cl) were 
supplemented to increase the length and to decrease the diameter of ZnO 
nanowires [43-45]. The prepared solution was heated in the oil bath to 
maintain uniform temperature during the synthesis of the ZnO nanowires. The 
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seeded cover glasses were dipped into the solution at a growth temperature of 
95oC for 2 h. After the reaction, the cover glasses were removed from the 
solution, and rinsed with deionized water. 
 
6.2.2. Cell viability assay  
Cell viability was determined by Trypan blue and Apoptosis assay. HEK293T 
cells grown on nanowires were observed at different time intervals during a 
period of 1 h to 96 h. After incubation, the cells were trypsinized with 0.05% 
trypsin solution. Ten microliter cell suspension mixed with 10 μl Trypan Blue. 
The 10 μl mixture was added into the hemocytometer, and the live cell 
amount under an optical microscope was counted to calculate the total number 
of cells.  Annexin V-Alexa Fluor 568 (eBioscience, USA) and 7-AAD 
double staining used for apoptosis of HEK293t cells on Nanowires was 
assayed by flow cytometer (BD Biosciences, USA). After treatment with 
FNW and VNW for 1 h to 96 h, cells were harvested with trypsin, washed 
twice with cold PBS, and resuspended in 200 µl binding buffer. Cells were 
transferred to a 1.5 ml culture tube, added to by 5 µl of Annexin V-Alexa 
Fluor 568, incubated at 4°C in the dark for 15 min, and then added 5 µl of 7-
AAD in the dark.  
 
6.2.3. Electron microscopy 
The morphology and structure of the nanowire arrays are investigated by 
using a field emission scanning electron microscope (FE-SEM, S-4300, 
Hitachi, Japan), transmission electron microscope (TEM, JEM-2100F, JEOL) 
as well as high-resolution transmission electron microscopy (HRTEM), and 
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X-ray diffraction (XRD, D/MAX-2500 V/PC, Rigaku, Japan). Cells grown on 
the nanowire-coated coverslips were also examined by SEM. After washing 
with phosphate-buffered saline (PBS), the cells were fixed with 
glutaraldehyde and sodium cacodylate solution (Karnovsky Fixate) for 2 h. 
Samples were rinsed with a 1% solution of osmium tetroxide in 0.1 M sodium 
cacodylate for 2 h, serially dehydrated with increasing concentrations of 
ethanol, critical point dried with hexamethyldisilazane, and then sputter-
coated with a platinum/palladium film. The samples were examined using a 
scanning electron microscope (Hitachi S4700, Japan) at an accelerating 
voltage of 15 kV. 
 
6.2.4. Binding of ZnO-binding peptides on nanowires 
Indicated amounts of ZnO-binding peptides (ZBP, amino acid sequences: 
RPHRKGGDARPHRKGGDARPHRKGGDA) labeled at their carboxyl 
terminals with fluorescein isothiocyanate (FITC, Peptron, Korea) were 
incubated with ZnO nanowires on a coverslip for 1 h at 37°C. The ZnO 
nanowires coated with ZBP-FITC were washed 3 times using PBS and then 
the relative binding of ZBP-FITC was assessed by measuring the fluorescence 
intensity using Infinite®M200 PRO (Taken, Switzerland) or used for cell 
culture. 
 
6.2.5. Confocal microscopy and flow cytometry 
ZnO nanowire-coated coverslips were incubated with 100 μM of ZBP-FTIC 
at 37°C for 1 h and washed 3 times using PBS to remove unbound peptides. 
Subsequently, HEK293 cells were seeded and incubated at 37°C for the 
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indicated time. The cells were fixed in 4% paraformaldehyde at room 
temperature for 20 min and permeabilized using 0.2% Triton X100 (Sigma-
Aldrich, USA) in PBS for 15 min. Cellular nuclei and actin cytoskeletons 
were stained with TO-PRO-3 (Molecular Probes, USA) and Alexa Fluor594-
Phalloidin conjugate (Molecular Probes, USA), respectively, according to the 
manufacturer’s instruction. The stained cells were washed 3 times with PBS 
and observed using an Olympus FV1000 laser confocal microscope 
(Olympus, Japan) and analyzed using the Fluoview software (Olympus, 
Japan). The cellular uptake of ZBP-FITC or GFP expression was examined 
after harvesting the cells from the coverslips using a flow cytometer (LSR II, 
BD Biosciences, USA). 
 
6.2.6. Intracellular delivery of peptides by endocytosis or 
penetration 
Cell Culture Media, centrifuge, nanwire coverslips maintained at Room 
temperature, 4°C and 37°C. After trypsinization, HEK 293T cells had been 
plated on the coverslips and centrifuged, HEK 293T cells with ZBPFITC 
nanowires and incubated at 4°C and 37°C for 5 min or 30 min and collected 
for FACS analysis to analyze temperature effect on intracellular delivery of 
peptides. 
 
6.2.7. Preparation of ZBP–streptavidin and biotin–DNA 
complex 
A reporter DNA encoding GFP expression cassette was amplified using a 
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PCR primer set (forward primer: 5′-biotinylated atagtaatcaattacggggtcattag-3′, 
reverse primer: 5′-tgaaaaaaatgctttatttgtgaaatt-3) and pEGFP-N1 vector 
(Clontech, USA) as a template. To generate ZnO NW and the biotinylated 
DNA complex, I produced recombinant ZBP–streptavidin protein. First, DNA 
encoding streptavidin was amplified by using a primer set (forward primer: 5′-
g̲a̲a̲t̲t̲c̲agctgaagctggtatcacc-3′, reverse primer: 5′-c̲t̲c̲g̲a̲g̲gtgatgggaagcagcgga-3′, 
EcoRI, and XhoI sites underlined) and pET21a-Streptavidin-Alive plasmid 
[27] (Addgene, USA) as a template. The DNA encoding streptavidin was 
ligated into pET28a vector containing the ZBP-encoding sequences (5′-
cgcccgcatcgcaaaggcggcgatgcgcgcccgcatcgcaaaggcggcgatgcgcgcccgcatcgcaaa
ggcggcgatgcg-3) after the DNA restriction. The recombinant plasmid 
encoding ZBP–streptavidin protein (pET28a/ZBP–streptavidin) was 
introduced into E. coli BL21 (DE3) strain (RBC biosciences, Taiwan). ZBP–
streptavidin protein was induced in the recombinant E. coli by using 0.1 mM 
isopropyl β-D-thiogalactoside (IPTG; Duchefa Biochemie, Netherlands) at 
16°C for 16 h and purified using Ni-NTA resin (Thermo Fisher Scientific, 
USA) according to the manufacturer’s instruction. 
 
6.2.8. Electrophoretic mobility shift assay (EMSA) 
The electrophoretic mobility shift assay was performed to confirm the 
complex formation of ZBP–streptavidin and biotinylated DNA, as previously 
described [46]. Briefly, 20 μg of biotinylated DNA was incubated with an 
indicated amount of ZBP–streptavidin at room temperature for 1 h. The 
resulting ZBP–streptavidin/biotin–DNA complexes were loaded on 1% 
agarose gel and visualized under UV light after electrophoresis in the 
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presence of ethidium bromide. 
 
6.2.9. Functionalizing nanowires and DNA transfection 
Coverslips were transferred into a 24 well cell culture plate, washed with 70% 
ethanol, and sterilized under UV for 1 h. Purified ZBP–streptavidin protein 
(80 μg) complexed with biotinylated DNA encoding GFP (20 μg) were added 
to the well containing a coverslip and incubated at 37°C for 1 h. The unbound 
complexes were removed by washing with PBS, and HEK293 cells (5 × 104 
cells per well) were plated. GFP expression in the cells was analyzed using 
confocal microscopy and flow cytometry as described above. 
 
6.2.10. Statistical analysis 
Data were analyzed using the Graph Pad Prism 5.01 software (Graph Pad 
Software, USA). Statistical analysis was performed using One-way ANOVA. 
Data are expressed as the mean ± standard deviation. The p-value less than 











6.3.1. Characterization of ZnO nanowire 
Morphological features of vertical (VNW) and fan-shaped (FNW) nanowires 
arrayed on glass coverslips prepared with a ZnO seed layer and ZnO 
nanoparticles, respectively, are presented in Fig. 1-1 A–D. The diameters of 
the ZnO nanowires range from 100 to 200 nm with lengths of 0.5 to 2.5 μm. 
X-ray diffraction (XRD) patterns of VNW and FNW confirm the 
characteristic peaks of ZnO with a hexagonal wurtzite structure (Fig. 1-2). 
Microstructural features of VNW and FNW are represented in Fig. 1-1 E–G. 
The selected area electron diffraction (SAED) pattern of the individual ZnO 
nanowire showed clear spots, confirming that the nanowire has a single-
crystalline wurtzite structure (Fig. 1-1 F). The spots can be indexed by (1010) 
and (0002) planes, where the d spacing is 0.161 nm for the (1010) plane (d 
(1010)) and 0.257 nm for the (0002) plane (d (0002)). Furthermore, the SAED 
pattern indicates that the ZnO nanowire was synthesized along the [0002] 
direction. The lattice fringes in the high-resolution transmission electron 
microscopy (HRTEM) image of Fig. 1-1 G are distinct, and the d spacing of 
the (0002) plane (d(0002)) measured from the fringe spacing of HRTEM is 
0.252 nm. These results match well with the d (0002) of 0.260 nm and 0.257 








 Figure 1-1. Morphological and microstructural analysis of ZnO nanowire 
arrays. Scanning electron microscopy (SEM) images present densely packed 
vertical ZnO nanowires (A. top view, B. side view) and fan-shaped nanowires 
(C. top view, D. side view). (E) Bright-field transmission electron microscopy 
(TEM) image is showing a single ZnO nanowire. The yellow arrows indicate 
the growth direction of [0002]. (F) Selected area electron diffraction (SAED) 
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spot pattern of the ZnO nanowire. (1010) and (0002) planes are indexed. (G) 
High-resolution TEM image of the ZnO nanowire. The solid yellow lines 

















 Figure 1-2. XRD patterns of vertical ZnO nanowire (VNW) and fan-
shaped ZnO nanowire (FNW) arrays. The characteristic peaks of wurtzite 











6.3.2. Cellular toxicity of ZnO nanowires 
In order to assess the cellular toxicity of ZnO nanowires, HEK293 cells were 
grown on VNW or FNW, and live cell counts were compared with those 
grown on a normal glass coverslip (Fig. 1-3). Live cell counts gradually 
increased in all the cultures after 12 h of lag phase, indicating that the 
HEK293 cells can replicate on glass coverslips coated with VNW or FNW 
arrays, albeit with a slightly lower growth rate than that of the normal 
coverslip (Fig. 1-3 A). To assess potential toxicity during the lag phase, I 
examined cellular necrosis and apoptosis (Fig. 1-3 B-C). Apoptotic cell death 
was detected as early as 1 h after incubation with VNW or FNW arrays, 
suggesting that apoptosis is rapidly induced upon direct contact with ZnO 
nanowires. It gradually increased up to 6 h after incubation and then 
decreased thereafter. Even though induction of apoptosis was also observed in 
the cells inoculated onto normal glass coverslips, ZnO nanowire itself, 
regardless of VNW or FNW, significantly enhanced apoptotic cell death more 
than a normal glass surface. The cells on FNW showed relatively higher rates 
(∼40%) of apoptosis during the early stage (∼3 h) of exposure when 
compared to those of the cells on VNW (∼26%) or normal coverslips 
(∼30%). Late apoptotic cells positive for both 7-aminoactinomycin D (7-
AAD) and Annexin V peaked at 6 h after incubation in all the experiment 
sets. The cells incubated on VNW and FNW showed significantly higher rates 
(33–35%) of late apoptotic phenotype than the cells on glass coverslips 
without nanowires (∼14%). Interestingly, necrotic cells were barely detected 
up to 3 h after incubation, but transiently peaked at 3–6% of cells in all the 
experimental sets at 6 h after inoculation, indicating that direct necrotic 
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damage, as measured by membrane penetration of 7-AAD without annexin V 

















Figure 1-3. The effect of ZnO nanowire arrays on cell viability. (A) 
HEK293 cells were grown on glass coverslips (CNT), including vertical 
nanowires (VNW) or fan-shaped nanowires (FNW), and their growth was 
monitored for up to 96 h. (B and C) Cellular apoptosis and necrosis were 
assessed by flow cytometry after annexin V and 7-AAD staining at the 






 6.3.3. Zinc oxide-binding peptide binding assay  
The zinc oxide-binding peptide was identified and analyzed in a previous 
study [18]. I analyzed the binding of ZnO nanowires, and FITC tagged Zinc 
binding peptide. A concentration of 10 to 320µM of ZBPFITC was incubated 
with FNW and VNW nanowires. At 80 µM, both the nanowires showed 
saturation (Fig.1-4). 
 
6.3.4. Cellular responses during the culture on ZnO 
nanowires 
 I further examined the cells grown on VNW or FNW when they were 
actively dividing by imaging analysis (Fig. 1-5). Scanning electron 
microscopy showed that the surface morphology of the cells on nanowire-
coated coverslips was similar to those of the cells grown on the normal cover 
glass after 24 h of incubation (Fig. 1-5 A). At 48 h of incubation, the cells on 
nanowire-coated coverslips can replicate as efficiently as those on normal 
glass slips and gradually cover the whole surface area (Fig. 1-5 B). When 
cellular actin and nuclei were stained, however, the cells grown on FNW 
showed a distinct arrangement and morphology of actin cytoskeletons and 
nuclei compared to those of the cells grown on normal coverslips and VNW 
(Fig. 1-5 B and C). Deformed nuclei were often observed in the cells that 
cover multiple FNW clusters. Actin cytoskeletons surround clusters of FNW 






Figure 1-4. Coating of ZnO nanowire arrays with ZBP-FITC. (A) Vertical 
(VNW) or fan-shaped (FNW) nanowires were incubated with indicated 
concentration of ZnO-binding peptides (ZBP) conjugate with FITC for 1 h at 
37°C. ZnO nanowire arrays coated with ZBP-FITC were assessed the relative 
binding of ZBP-FITC by measuring the fluorescence intensity. (B) 
Representative images of ZnO nanowire arrays coated with ZBP-FITC. DIC, 











Figure 1-5. Morphology of cells grown on ZnO nanowire arrays. (A) SEM 
images of HEK293 cells grown on glass coverslips (CNT), vertical nanowires 
(VNW), and fan-shaped nanowires (FNW) at 24 h after cell culture. (B and C) 
Cells grown on nanowire arrays for 48 h were stained with TO-PRO-3 and 
Alexa Fluor594-Phalloidin conjugate to observe cellular nuclei (blue) and the 
actin cytoskeleton (red), respectively. Magnified image of cells grown on 
FNW shows deformed nuclei and distinct arrangement of actin cytoskeletons, 
lamellipodia, surrounding the ZnO nanowire clusters at the contact edges (C, 
white arrowheads). (D) Cells were grown on nanowire arrays coated with 
ZBP-FITC (green) for 24 h, and cell nuclei and actin cytoskeleton were 
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stained with TO-PRO-3 and phalloidin. Fluorescence images of cells and ZnO 
nanowires were assessed by confocal scanning of z-stacks and orthogonal 
views (yz and xz) are shown in the right and bottom panels. Excitation (ex.) 
and emission (em.) wavelengths for detecting the fluorescent probes by 
confocal microscopy are as follows; FITC: ex. 495 nm, em. 519 nm, Alexa 
Fluor594-Phalloidin: ex. 581 nm, em. 609 nm, and TO-PRO-3: ex. 642 nm, 

















6.3.5. Intracellular uptake of peptides coated on ZnO 
nanowires  
In order to observe the structures at the contact area between the cells and 
nanowires in more detail, I applied ZnO-binding peptide (ZBP) conjugated 
with FITC. The binding of ZBP-FITC to VNW or FNW was measured at 
titrated concentrations of ZBP-FITC after incubation for 1 h and binding of 
ZBP-FITC was measured by fluorescence intensities and fluorescent 
microscopy (Fig. 1-4). Then, cells were cultured on VNW or FNW coated 
with ZBP-FITC for 24 h and observed under a confocal microscope. A 3D 
reconstitution of confocal scanning images shows actin cytoskeleton and 
lamellipodia formation at the contact edges with FNW, whereas gross 
organization of the cellular structures grown on VNW was similar to those of 
the cells grown on normal coverslips (Fig. 1-5 D). It is also notable that the 
deformation of nuclei of the cells grown on FNW is primarily caused by 
spatial constraint of nanowire clusters. 
To investigate the cellular mechanisms involved in the delivery of 
peptides, peptide-coated nanowire arrays were incubated with cells at 4°C for 
30 min, and the cell uptake of FITC-labelled peptides was measured by flow 
cytometry. As seen in Fig. 1-6 C, intracellular delivery of peptide was 
remarkably reduced when cells were incubated at 4°C with VNW and FNW, 
suggesting that active cellular processes such as endocytosis may play a 
significant role in the intracellular uptake of peptides on the nanowires. 
Nevertheless, a proportion of cells were still positive for the FITC signal, 
suggesting that a direct penetration of the peptides into the cells may also 
occur. More efficient intracellular delivery was consistently observed when 
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cells were incubated at 4°C with FNW (60%) than with VNW (25%) (Fig. 1-6 

























Figure 1-6. Intracellular uptake of peptides coated on ZnO nanowires.  
(A and B) HEK293 cells were incubated on ZnO nanowire arrays coated with 
ZBP-FITC at 37°C for the indicated times and analyzed by flow cytometry. 
Live cells were gated based on a scatter plot. Mean fluorescence intensities of 
cells from triplicated assays are presented (B). (C) Flow cytometric analysis 
of cells incubated on ZnO nanowire arrays coated with ZBP-FITC either at 
4°C or 37°C for 30 min. Cells incubated on nanowire arrays without ZBP-
FITC coating were presented as gray histogram and cells on those coated with 
ZBP-FITC are presented as blue (VNW) or red (FNW) histograms. (D) Cells 
were incubated at 4°C on VNW and FNW coated with ZBP-FITC for 30 min 
and collected for FACS analysis. Representative flow cytometric scatter plots 
(left panels) and the graph showing the percentage of FITC positive cells from 
triplicated experiments (right panel) are presented.  CNT: nanowires without 
ZBP-FITC coating, VNW: vertical nanowires, FNW: fan-shaped nanowires. 











6.3.6. Saturation of ZBP streptavidin binding on 
nanowires 
To confirm the binding saturation of a protein on nanowires, 300 µg of ZBP 
streptavidin incubated for a different time interval. The unbound protein is 
collected and checked for the concentration using BSA assay. It was 
confirmed that 150 µg of ZBP streptavidin protein get saturated on ZnO 
nanowires, after the 4 h of incubation at 37oC (Fig. 1-7 A-B). 
 
6.3.7. Analysis of ZBP streptavidin protein-biotinylated 
DNA binding 
Electromobility shift assay (EMSA) confirms ZBP streptavidin and 
biotinylated GFP DNA binding on ZnO nanowires. When biotinylated DNA 
(20 µg) was incubated with 10, 20, 40, 80, or 160 µg of ZBP streptavidin for 1 
h, approximately 80 µg ZBP streptavidin protein is sufficient to bind ~ 90 % 
of input DNA as visualized by gel electrophoresis and quantification by 












Figure 1-7. Complex formation of ZBP-streptavidin and biotin-labeled 
DNA. (A) Schematic diagram of complex formation strategy for ZBP 
(purple)-streptavidin (green) and biotin (red)-labeled DNA (orange) on ZnO 
nanowire (blue) array. (B) Kinetic binding of ZBP-streptavidin to ZnO 
nanowire array on a coverslip. Clustered ZnO NW array on a coverslip were 
incubated with 300 μg purified ZBP-streptavidin at 37οC for indicated time 
interval and the bound proteins were assessed by BCA protein assay kit (see 
Methods). (C and D) The electrophoretic mobility shift assay was performed 
to confirm the complex formation of ZBP-streptavidin and biotinylated DNA. 
Indicated amount of ZBP-streptavidin protein was incubated with biotinylated 
DNA encoding GFP expression cassette and the resulting complexes were 5 
visualized under UV light after agarose gel electrophoresis (C). Relative 
binding of biotinylated DNA to ZBP-streptavidin was presented from 
triplicate experiments. Error bar, ± SD. 
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6.3.8. Role of nanowire penetration in gene expression  
To link DNA molecules to ZnO nanowires, I utilized a ZBP-fused streptavidin 
and biotinylated DNA encoding expression cassette for green fluorescence 
protein (GFP) (Fig. 1-7). A fraction (∼8%) of HEK293 cells incubated with 
FNW coated with ZBP–streptavidin and biotinylated DNA expressed GFP at 
48 h after incubation, whereas GFP expression was barely observed in cells 
incubated with FNW only or FNW with free biotinylated DNA (Fig. 1-8). 
Expression of GFP in cells incubated with VNW complexed ZBP–










Figure 1-8. Intracellular delivery of DNA coated on clustered ZnO 
nanowire arrays. (A) Fluorescence image of HEK293 cells transfected with 
DNA encoding GFP-expression cassette. Cells were incubated on FNW arrays 
coated with linear DNA for 48 h and then stained with TO-PRO-3 and 
phalloidin for visualization of nuclei (blue) and the actin cytoskeleton (red), 
respectively. Excitation (ex.) and emission (em.) wavelengths for detecting 
the fluorescent probes by confocal microscopy are as follows; GFP: ex. 488 
nm, em. 509 nm; Alexa Fluor 594-Phalloidin: ex. 581 nm, em. 609 nm; and 
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TO-PRO-3: ex. 642 nm, em. 661 nm. DIC: differential interference contrast, 
white bar: 10 μm. (B) FACS histograms showing GFP expression for different 
experimental groups. Percentile of GFP-positive cells was compared among 
the indicated experimental groups. Error bars indicate SD of experimental 






















Two types of 3 dimensional ZnO nanowire arrays were synthesized by a 
hydrothermal method and named them based on Morphology as vertical 
(VNW) and fan-shaped (FNW) nanowires. This Study has investigated 
potential Information of different physical conformation of the 3D ZnO 
nanowires with cellular responses, cytotoxicity as well as the efficacy of 
intracellular delivery of associated bio-macromolecules. Morphological 
features of FNW or VNW arrays in glass coverslips prepared on ZnO seed 
layer or ZnO nanoparticles, respectively, are presented in Fig 1-1. The 
diameter of ZnO nanowires range from 100 to 200 nm and the length are from 
0.5 to 2.5 µm. X-ray diffraction patterns confirm the typical peaks of the 
wurtzite structure of ZnO crystal structures (Fig. 1-2).  
 In order to assess the cellular toxicity of ZnO nanowires, HEK293 
cells were grown on VNW or FNW. The necrotic phenotypes may not be 
specific to ZnO nanowire arrays since normal glass coverslips also induced a 
similar degree of necrosis with the same time kinetics. It is also noteworthy 
that there was a subsequent rise in cellular necrosis between 24 and 48 h of 
incubation when cells were actively growing, indicating that physical damage 
causes cellular necrosis in a small fraction (<10%) of cells. Again, this minor 
rate of necrosis seems to be independent of ZnO nanowire arrays since normal 
glass coverslips also induced a similar degree of necrosis with similar time 
kinetics. Considering that cellular apoptosis gradually decreased during the 
exponential growth phase, the second rise in necrotic phenotype may reflect 
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physical damage to cellular membranes while cells start to rapidly grow in the 
new culture environment after the lag phase. Taken together, the degree of 
cell apoptosis, but not necrosis, was higher in the cells incubated on ZnO 
nanowire-coated coverslips than normal glass coverslips during the initial 
stage of incubation. Since cellular apoptosis was rapidly induced during the 
early phase (∼6 h) of incubation with ZnO nanowire arrays and gradually 
declined thereafter, cellular adaptation potentially helps to overcome 
apoptotic stress endowed by ZnO nanowire contact while cells start to 
replicate on the foreign substrate. These findings provide interesting 
information on how cells respond and adapt to the inorganic nanowire 
substrate on glass coverslips. Although most of the current studies on 
inorganic nanowires have reported “minimal” toxicity based on viability and 
toxicity tests after the cells completely settle down and/or actively replicate on 
the nanowire structures (usually 24–48 h after incubation), our current 
findings on the differential kinetics of cellular apoptosis and necrosis in 
response to ZnO nanowire arrays underscore the importance of studying 
kinetics on cellular stress responses when cells are newly exposed to a foreign 
nanowire substrate. 
 Surface functionalization of nanowires is one of the essential factors 
to bind the biomolecules on the nanowire for any biological uses. Until now, 
alkoxysilanes has been widely used for the surface functionalization of 
nanowires, to bind biomolecules [48-49]. Here I have used previously 
reported Zinc oxide binding peptide for surface functionalization of nanowires 
[18, 47]. During imaging analysis, I observed close contact of cellular 
surfaces with ZBP-FITC-coated nanowires. Therefore, I next assessed the 
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intracellular delivery of the peptides coated on ZnO nanowires. As shown in 
Fig 1-6 A and 1-6 B, all the live cells collected after 30 min of incubation on 
ZBP-FITC-coated nanowire arrays were positive for FITC signal and the 
fluorescence intensities were saturated thereafter, albeit with slight 
fluctuations in signal intensities. These results indicate that the peptide 
molecules coated on the nanowires are efficiently and rapidly delivered into 
cells. Rapid saturation of the peptides also suggests that cells potentially 
uptake the peptide molecules coated on the tips of ZnO nanowires right after 
cellular contact. When I compared the morphological difference of 293t cells 
on FNW, VNW, and normal cover glass, I find out that the cells are trying to 
wrap FNW using filopodia (Fig. 1-5 C). Previously, it was shown that on SiO2 
nanopillars less than 300 nm in diameter and arranged at 1 μm intervals, the 
cell membrane wraps around the entirety of a nanopillar without the 
nanopillar puncturing the cell [25]. On the other hand, cells sit atop of arrays 
of larger, more closely spaced nanopillars [25]. Although our ZnO nanowires 
have a diameter of less than 200 nm, they are densely packed, so cells sit on 
VNW or wrap individual clusters of FNW via lamellipodia formation. Thus, 
cellular membranes mainly contact tips of ZnO nanowires (Fig. 1-5 D) and 
may rapidly take up peptides coating the tips of nanowires. These results 
support that FNW mediates more efficient physical penetration during the 
early contact period. Considering that FNW induced more cellular apoptosis 
than VNW during the early phase (∼3 h) of incubation, without cellular 
necrosis in both ZnO nanowire arrays during this time frame (Fig. 1-3 C), the 
physical pressure exerted by the unevenly distributed FNW array might be 
more apoptogenic but insufficient to cause necrotic damage to cellular 
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membranes. In addition, the pressure imposed on cells by gravitation during 
FNW contact may allow for better intracellular access of the associated 
peptides than VNW contact at 4°C (Fig. 1-6 C-D).  
 Previously, two mechanisms of elastic cell membrane penetration 
have been proposed: “impaling penetration” as cells land onto a bed of 
nanowires and “adhesion-mediated penetration,” which occurs as cells spread 
onto the substrate and generate adhesion force [50]. The difference in efficacy 
of intracellular delivery of the associated peptides on FNW and VNW at 4°C 
during the early phase (~ 30 min) of incubation might be due to the degree of 
impaling penetration since cellular spread on substrate is restricted at 4°C 
during the short incubation period (Fig. 1-6). Contact between cellular 
membrane and ZnO nanowire arrays potentially start from the tips of 
nanowires such that if nanowires are tilted or vertical, asymmetric elastic 
strain may affect subsequent contact [51-52]. The asymmetric contact of 
angled nanowires in FNW with cellular membrane may allow for better 
penetration of plasma membrane and actin cytoskeleton [53]. Transient 
penetration may occur shortly after seeding cells on the nanowire arrays and 
then further continued by lipid bilayer drift driven by surface tension [54]. 
The enhanced full penetration of the plasma membrane by FNW is further 
supported by the detectable gene expression of associated DNA (Fig. 1-9). In 
order to be expressed in eukaryotic cells, the DNA encoding an expression 
cassette must be delivered into the nucleus after passing through the plasma 
membrane. Since endocytosed molecules are generally delivered into 
lysosomes where cargo are degraded, GFP expression from delivered DNA 
demonstrates a direct penetration of the cellular membrane into nuclei by 
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FNW in a fraction (~ 8% in this study) of cells. Cellular penetration by FNW 
can be further intensified by cell-substrate adhesion tension during the initial 
contact phase, causing the cell membrane to spread onto the glass coverslip 
and deform toward the FNW (adhesion model). The full penetration of the 
plasma membrane, which is sufficient to mediate intracellular delivery of 
large DNA molecules, likely occurs at the apex of ZnO nanowires by the 
“tent-adhesion mechanism” during initial cell spreading [55]. It was shown 
that cellular penetration occurs rapidly within 30 min after seeding the cells 
on hollow nanowires and plateau after an extended period of time. Once cells 
engulf nanowires, cells do not further generate stress, thereby avoiding 
membrane failure [55-56]. 
Efficient intracellular delivery of biomacromolecules non-covalently 
associated with ZnO nanowires can be mediated by active cellular uptake, 
such as endocytosis, and/or direct penetration during the early phase of 
cellular contact. In addition, FNW might induce penetration of plasma 
membrane more efficiently than VNW, as evidenced by enhanced DNA 
transfection, but generates more apoptotic stress during the initial contact 
phase.  Nevertheless, cells can survive and grow efficiently on both types of 
ZnO nanowire arrays with marginal toxicity after the initial lag phase. These 
results indicate that ZnO nanowire arrays could be an attractive nanomaterial 










 Application of radially grown ZnO nanowires on 
poly-L-lactide microfibers complexed with a 















Zinc oxide (ZnO)-based nanocomposites have shown promising potential for 
various biomedical applications, including bioimaging, drug delivery, and 
vaccine development, due to its multifunctionality and biocompatibility [15, 
18, 57]. Notably, it has been consistently shown that ZnO nanoparticles (NPs) 
possess adjuvant potential as vaccine carrier when combined with specific 
antigens [15, 18]. ZnO NP itself can exert immunomodulatory and 
inflammatory effects on antigen-presenting phagocytic cells (APCs), such as 
macrophages and dendritic cells [16, 59]. The immune-stimulatory function of 
ZnO nanocomposites might be due to induction of reactive oxygen species 
(ROSs), inflammatory cytokines, and cellular activation in APCs, which can 
link to antigen-specific adaptive immune responses, as well as intrinsic basal 
toxicity in vivo [36, 60]. It is notable that ZnO NP has the most drastic 
immunological effects in APCs among several inorganic NPs (TiO2, TiO2-
silica, single-walled carbon nanotubes, and multi-walled carbon nanotubes) 
[61]. Moreover, surface modification of ZnO nanocomposites with specific 
peptides possessing a high affinity to the metal oxide composites also enables 
them to further enhance the antigen-specific adaptive immunity, including 
antibody and T cell responses in vivo [15, 18]. 
In the previous chapter, I also found that ZnO nanowires (NWs) can 
efficiently deliver associated biomacromolecules, including peptides and 
DNA, into eukaryotic cells if appropriately modified in a 3-dimensional 
conformation. It was also confirmed that radially grown “fan-shaped” ZnO 
nanowires (FNWs) on a coverslip can efficiently deliver the associated 
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peptides and DNA into eukaryotic cells via transient penetration of plasma 
membrane as well as cellular endocytosis, whereas delivery of the 
biomacromolecules on densely packed vertical ZnO nanowires (VNWs) might 
be primarily mediated by endocytosis with bare membrane penetration. 
Indeed, FNW can mediate intracellular delivery of DNA into the nucleus and 
its gene expression, confirming intracytoplasmic penetration crossover the 
cytoplasmic membrane, whereas VNW failed to do so. This phenomenon 
suggested that contact of angled nanowires with the plasma membrane and 
subsequent cellular spread can intensify membrane tension and induce 
transient penetration of plasma membrane, thereby enhancing the delivery 
into cytoplasm and nucleus. The delivery of an antigen into host cells, 
especially into APCs, is a critical step to determine antigen processing and 
presentation pathways to CD8 and CD4 T cells via MHC class I and II 
pathways [62]. Given that this two different antigen processing and 
presentation pathways are primarily dependent on antigen location in cellular 
cytoplasm and within intracellular vesicles, respectively, intracellular delivery 
of a protein antigen into cytoplasm may further enhance antigen-specific CD8 
T cell responses mediated by MHC class I antigen presentation pathway, 
which can be efficiently linked to antigen-specific cytotoxic T lymphocyte 
(CTL) responses, critical players in anti-tumor immunity [34, 62- 64]. 
In this study, I investigated whether ZnO nanowires formed the 
unique 3-dimensional structure on poly-L-lactic acid (PLLA) microfibers, a 
biocompatible organic matrix, can induce a tumor antigen-specific CTL 
response and suppress tumor growth in vivo. Radially grown ZnO nanowires 
on PLLA fibers were complexed with a well-known tumor antigen, 
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carcinoembryonic antigen (CEA), fused with ZnO-binding peptide to exploit 
as a novel intracellular antigen delivery system [29]. I also confirmed the 
immune stimulatory effect of the inorganic-organic hybrid nanocomposites in 
vitro using phagocytic dendritic cell, a cellular bridge of innate and adaptive 
immunity [65]. Immunization with the CEA-coated hybrid nanocomposites 
can not only enhance the antigen-specific T cell responses but also suppress 
tumor growth significantly better than PLLA fibers mixed with CEA in vivo 
mouse model, demonstrating that incorporation of ZnO nanowires into the 
hybrid composite has promising potential as a vaccine adjuvant for antigen 
















 7.2. Material Methods 
  
7.2.1. Synthesis of PLLA fiber-ZnO nanowire composites  
PLLA microfiber-ZnO nanowire composites were synthesized as follows and 
supplied by Professor Young Keun Kim’s laboratory, Korea University. 
Before the electrospinning process, the solution of PLLA polymer and ZnO 
nanoparticles (NPs) was prepared. Hexadecyltrimethylammonium bromide 
(CTAB) capped ZnO NPs with the size of 5 nm are synthesized by alkaline 
solution-based method according to a previous report. Then, PLLA (15 w/v 
%) polymer is dissolved in chloroform for several hours with magnetic 
stirring. The ZnO NP solution with the concentration of 10 mg/ml in ethanol 
is added to prepared PLA solution and mixed with vortex mixer and 
ultrasonication. The blended solution is injected into a 10 mL syringe which is 
mounted a 21-gauge metal needle tip with a diameter of 0.5 mm. A distance 
between needle and collector is adjusted to 10 cm. PLLA fiber-ZnO NP 
membranes are collected by electrospinning method with the applying voltage 
of 10 kV. Finally, PLA fiber-ZnO nanowires composites are synthesized via 
hydrothermal method for which the ZnO crystals are grown from ZnO NP 
embedded in PLLA fiber. 10 mM of zinc nitrate hexahydrate, 
(Zn(NO3)∙6H2O) and 10 mM of hexamethylenetetramine (HMTA, C6H12N4) 
are dissolved in deionized water to synthesize the ZnO nanowires on the 
PLLA fiber. 
 




The morphology and microstructure of the ZnO NPs and PLLA fiber-ZnO 
nanowires composites are analyzed using scanning electron microscopy 
(SEM, SU 70 Hitachi, Japan) at an accelerating voltage of 15 kV. The crystal 
structure and crystallite size of the samples are determined by measuring 
powder X-ray diffraction (XRD, PANalytical, X’Pert ProMPD) with Cu Kα 
radiation (λ = 1.5406 Å) with Cu Kα radiation (λ = 1.5406 Å). Measurements 
were conducted in θ–2 θ geometry from 30◦ to 60◦ at 45 kV and 40 mA tube 
power.  
 
7.2.3.  Mechanical fragmentation of PLLA fiber-ZnO 
nanowire composites  
In order to mechanically fragment the composites, 10 mg of PLLA or PLLA-
ZnO membranes were dispersed in dimethyl sulfoxide (DMSO) for 30 min 
and serially passed through ten times using a syringe with 18G, 23G, and 26G 
needles. The solution containing fragmented composites were then loaded on 
top of 80% sucrose solution and PLLA-ZnO nanocomposites were separated 
from PLLA fibers by density gradient centrifugation (3,515 x g, 30 min). The 
composites collected from the bottom layer were collected and further 
filtrated using 70 µm cell strainer (Sigma Aldrich, USA). The final 
fragmented PLLA-ZnO nanocomposites were washed with Phosphate-
buffered saline (PBS) and used for further application. The size distribution of 
the fragmented complexes was measured by manually under the microscope. 
The procedure for fragmentation and separation of PLLA-ZnO 
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nanocomposites was summarized in Figure 2-2.  
 
7.2.4. ZBP-FITC binding PLLA fiber-ZnO nanowire 
composites  
Indicated amounts of ZnO-binding peptides (ZBP, amino acid sequences: 
RPHRKGGDARPHRKGGDARPHRKGGDA) labeled at their carboxyl 
terminals with fluorescein isothiocyanate (FITC, Peptron, Korea) were 
incubated with 250 µg of PLLA and PLLA-ZnO nanocomposite for 1 h at 
room temperature. The PLLA and PLLA-ZnO nanocomposites coated with 
ZBP-FITC were washed 3 times using PBS. This complex is resuspended in 
100 μl of PBS, and then transferred to a 96 well black plate for fluorescence 
intensity measurement using Infinite®M200 PRO (Taken, Switzerland) or 
used for cell culture. 
 
7.2.5. ZBP–CEA binding on PLLA fiber-ZnO nanowire 
composites  
Different concentrations of ZBP–CEA were incubated with 250 μg of PLLA 
and PLLA-ZnO nanocomposites for 1 h at room temperature. The complex 
was washed 5 times using PBS. The bound proteins on PLLA and PLLA-ZnO 
nanocomposite were collected by centrifugation and quantitated by coomassie 
blue staining after SDS-PAGE. 
 
7.2.6. Cellular uptake of ZBP-FITC coated on PLLA 
fiber-ZnO nanowire composites 
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PLLA and PLLA-ZnO nanocomposite were incubated with 6000 μM of ZBP-
FTIC at room temperature for 1 h and washed 3 times using PBS to remove 
unbound peptides. Subsequently, this complex is incubated with DC2.4 at 37 
°C for the indicated time. The cellular uptake of ZBP-FITC was examined 
after harvesting the cells using a flow cytometer (LSR II, BD Biosciences, 
USA). 
 
7.2.7. Activation of DC2.4 cells cultured with PLLA fiber-
ZnO nanowire composites  
DC2.4 cells cultured PLLA and PLLA-ZnO nanocomposite s were washed 
with ice-cold FACS buffer (PBS containing 1% bovine serum albumin [BSA] 
and 1 mM EDTA) and blocked on ice for 30 min with ultra-block solution 
containing 10% rat sera, 10% hamster sera, 10% mouse sera (Sigma, USA), 
and 10 μg/ml of 2.4G2 monoclonal antibody (BD Pharmingen, USA).  DC 
maturation was examined after staining with FITC-conjugated anti-I-Ab 
(clone AF6-120.1; BD Pharmingen, USA), PE-conjugated anti-CD40 (clone 
3/23; BD Pharmingen, USA), APC-conjugated anti-CD80 (clone 16-10A1; 
eBioscience, USA), and PE/Cy7-conjugated anti-CD86 (clone GL-1; 
BioLegend, USA) for 30 min on ice. The cells were analyzed using a FACS 
(LSR II, BD Biosciences, USA) flow cytometer. Data were analyzed by 
FlowJo software version 8.8.6 (FlowJo, USA). 
 
7.2.8. Viability of DC2.4 cells cultured with PLLA fiber-
ZnO nanowire composites  
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DC2.4 cells were maintained in Roswell Park Memorial Institute medium  
(RPMI 1640) (Welgene, Korea) supplemented with 10% heat-inactivated fetal 
bovine serum (FBS) (Welgene, Korea), 100 U ml−1 penicillin, and 100 μg 
ml−1 streptomycin (Gibco BRL, USA) at 37°C in the presence of 5% CO2. 
The viability of the DC2.4 cells cultured with PLLA and PLLA-ZnO 
nanocomposite observed for 24 h by trypan blue staining and apoptosis assay. 
The cells were collected by trypsinization, and live cells were counted after 
trypan blue staining. Cellular apoptosis and necrosis were assessed after 
staining with annexin V-Alexa Fluor 488 (Biolegend, USA) and 7-
aminoactinomycin D (7-AAD, (Biolegend, USA) using a flow cytometer 
(LSR II, BD Biosciences, USA) according to the manufacturer’s instruction. 
 
7.2.9. Cytokine analysis 
Cytokines secreted in culture supernatants were analyzed by cytometric bead 
array using a Mouse Inflammation Kit (BD Biosciences, USA), according to 
the manufacturer's instructions. Culture media were changed before DC2.4 
stimulation and the production of tumor necrosis factor (TNF) -α, IL-1β, IL-6, 
and IL-10 from stimulated DCs were measured at 18 h after incubation. 
 
7.2.10. Intracellular cytokine staining 
Lymphocytes collected from the spleen of immunized mice were cultured for 
16 h in RPMI 1640 medium supplemented with 10% heat-inactivated FBS, 50 
nM β–ME (Invitrogen), 100 units/ml penicillin-streptomycin, 2 mM L-
glutamine (Welgene, Korea), and 20 μg/ml of purified CEA proteins in 24-
well, flat-bottomed culture plates (5 × 106 cells/well). After incubation, 
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GolgiPlug (BD Biosciences, USA) was added for 6 h. Lymphocytes were 
washed three times with ice-cold FACS buffer. Cells were blocked with ultra-
block solution for 30 min on ice and stained with BV-605 and Pe-cy7-
conjugated CD4 and CD8 antibodies (BD Pharmingen, USA) for 30 min at 
4°C. After surface CD4 or CD8 staining, cells were washed three times with 
ice-cold FACS buffer and subjected to intracellular cytokine staining using 
the Cytofix/Cytoperm kit according to the manufacturer`s instructions (BD 
Biosciences, USA). Intracellular interferon- (IFN-γ) was stained using an 
APC-conjugated anti-IFN-γ. XMG1.2; BD Pharmingen, USA) for 30 min at 
4°C. The stained cells were analyzed with a FACS Canto II flow cytometer. 
Data were analyzed by FlowJo software version 8.8.6). 
 
7.2.11. Cytotoxic T lymphocyte activity 
Fourteen days after the second vaccination, splenocytes were harvested from 
the immunized mice and CTL assays were performed using a crystal 
violet/MTT absorbance assay as described previously [30]. CTLs were 
generated by stimulating the splenocytes with synthetic ZBPCEA peptide 16 h 
followed by incubation with MC38/CEA cells as a target for 24 h. After 
washing, the target cells were stained with crystal violet (4 mg/ml in PBS) for 
30 min at room temperature. The plate was then washed with PBS and the 
cells lysed using methanol. Target cell survival was analyzed by measuring 
the absorbance at 570 nm. 
 
7.2.12. Tumor growth and survival 
C57BL/6 mice (Orient Bio, South Korea) were housed and maintained in the 
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specific pathogen-free facility at Seoul National University (SNU) College of 
Medicine. Animal experiments were performed after approval by the SNU 
IACUC (permission ID: SNU090805-5). Tumor-bearing mice were humanely 
sacrificed when tumors reached over 2 cm3 at the day of observation. Six-
week-old C57BL/6 mice were injected subcutaneously at the right flank with 
MC38/CEA cells (1 × 105 cells/mouse). At 7 d after tumor cell injection, the 
mice were immunized at the tail base with the indicated complex three times 
at weekly intervals. Five mice were used for each group. Tumors were 
measured by digital caliper (TESA SHOP-CAL, Willrich Precision, 
Switzerland). The tumor volume (mm3) was calculated as (A x B2)/2, where 
A is the long diameter, and B is the short diameter. Tumor-bearing mice were 
humanely sacrificed with CO2 asphyxiation when tumors reached over 2 cm 
in diameter at the day of observation, and the surviving mice were monitored 
up to 30 days after tumor inoculation. 
 
7.2.13. Isolation of tumor-infiltrating leukocytes  
Tumor tissues obtained aseptically from mice and cut into fragments, washed 
twice with PBS, and then digested with an enzyme cocktail (DNase and 
Collagenase IV, Sigma Aldrich, USA) as described previously [86]. The 
resulting cell suspension was filtered through nylon mesh screens to remove 
cell clumps, washed three times with PBS and resuspended in ice-cold FACS 







7.3.1. Characterization and fragmentation of PLLA fiber-
ZnO composites  
Characteristic features of synthesized PLLA fiber-ZnO nanowire composites 
are presented in Fig. 2-1. As shown in scanning electron microscopy (SEM) 
images, ZnO nanowires are grown uniformly on the PLLA fibers. The 
diameter of PLA fiber is 1.25 μm in average. After 2 h of hydrothermal 
reaction, the ZnO nanowires have a diameter of 122.5 ± 4 nm, and a length of 
1,375 ± 247 nm. We measure the XRD patterns to analyze the crystal 
structures of the composites. The diffraction peaks in Figure 2-1 B are 
appeared at 31.8°, 34.4°, 36.3°, 47.5°, 62.8°, and 67.7°, which can be assigned 
to (100), (002), (101), (102), and (110) planes of the ZnO nanowires with 
hexagonal closed packed (hcp) structure (PDF no. 36-1451), respectively. The 
diffraction peaks of ZnO nanowires become sharp as ZnO nanowires are 
grown from ZnO NPs. In order to obtain injectable forms of PLLA fiber-ZnO 
nanowires composites for in vivo application, I fragmented and collected the 
PLLA fiber-ZnO nanowires composites by density gradient centrifugation 
after mechanical shearing in DMSO solution using a syringe with 18G, 23G, 
and 26G needles (Fig. 2-2). Approximate Sizes of the fragmented composites 







Figure 2-1. Morphological and microstructural analysis of PLLA fibers 
and PLLA fiber-ZnO nanowires composites. (A) SEM images of PLLA 
fibers (top left) and PLLA fiber-ZnO nanowires composites (left bottom and 
right with different magnifications). (B) XRD patterns of PLLA fiber (blue), 
PLLA fiber-ZnO nanowires composite (red). The ZnO peak positions are 
denoted in the bottom of the panel by the black vertical line. 
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7.3.2. Effect of PLLA fiber-ZnO nanowire composites on 
cell viability 
In order to assess the cellular toxicity of PLLA fiber-ZnO nanowires 
composites, DC2.4 cells were treated with the nanocomposites, and live cell 
counts were compared with untreated control cells or PLLA fiber-treated cells 
(Fig. 2-3). Live cell counts gradually increased in the cultures after 6 h of lag 
phase, indicating that DC2.4 cells can replicate in the presence of PLLA fiber-
ZnO nanowires composites, albeit with lower growth rates than those of 
untreated cells or PLLA fiber-treated cells (Fig. 2-3 A). To assess for potential 
toxicity during the lag phase, I examined cellular necrosis and apoptosis (Fig. 
2-3 B and 2-3 C). Apoptotic cell death was gradually increased up to 12 h 
after incubation with PLLA fiber-ZnO nanowires composites, suggesting that 
cellular apoptosis is induced in a fraction of cells by treatment of PLLA fiber-
ZnO nanowires composites, and then decreased to normal range, comparable 
to those of untreated or PLLA fiber-treated cells in 24 h after incubation. Even 
though induction of apoptosis was also observed in cells treated with PLLA 
fibers, ZnO nanowires might be responsible for enhanced apoptotic cell death. 
Cells treated with PLLA fiber-ZnO nanowires composites showed similar 
degree (4.1 ~ 5.3%) of early apoptotic phenotype when compared to those 
(4.1 ~ 5.5%) treated with PLLA fibers up to 24 h of incubation. However, late 
apoptotic cells positive for both 7-aminoactinomycin D (7-AAD) and annexin 
V peaked (~ 25.5%) at 12 h after incubation in cells treated with PLLA fiber-
ZnO nanowires composites, whereas they were observed in significantly 
lower degree (4.7 ~ 14.5%) when treated with PLLA fibers throughout the 
incubation period. Interestingly, necrotic cells were barely detected (generally 
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less than 2.0%) in all the experimental groups, suggesting direct physical 
damages, as measured by membrane penetration of 7-AAD without annexin V 



























Figure 2-2. Schematic diagram and representative images of steps for 












Figure 2-3. The effect of PLLA fiber-ZnO nanowires composites on cell 
viability. (A) DC2.4 cells were grown in the absence (CNT) or presence of 
250 µg of PLLA fibers (PLLA) or PLLA fiber-ZnO nanowire composites 
(PLLA-ZnO), and their growth was monitored for up to 24 h. (B and C) 
Cellular apoptosis and necrosis were assessed by flow cytometry after annexin 




7.3.3. Binding of antigen with PLLA fiber-ZnO nanowire 
composites  
In order to utilize PLLA fiber-ZnO nanowire composites as an antigen 
delivery system, I used a ZnO-binding peptide (ZBP) and examined its 
binding capacity to the nanocomposites (Fig. 2-4). The binding of ZBP-FITC 
to PLLA fiber-ZnO nanowire composites was assessed at titrated 
concentrations of ZBP-FITC after incubation for 1 h and then measured by 
fluorescence intensities and fluorescent microscopy (Fig. 2-4 A-B). ZBP-
FITC was saturated at ~3.2 µM with 250 μg of PLLA fiber-ZnO nanowire 
composites. Although the peptide can bind nonspecifically to PLLA fibers 
and was saturated at the same peptide concentration, the amount of bound 
peptides was approximately one-third of those bound to PLLA fiber-ZnO 
nanowire composites, as measured by fluorescence intensity (Fig. 2-4 B). 
Next, I used recombinant carcinoembryonic antigen (CEA) fused with 3× 
ZBP as a model antigen to investigate the applicability of the nanocomposites 
for cancer immunotherapy. Consistently, ZBP-CEA showed enhanced binding 
to PLLA fiber-ZnO NANOWIRES composites when compared with PLLA 
fibers (Fig. 2-4 C-D). Approximately 22 µg of ZBP-CEA protein showed 
saturated binding to 250 µg of PLLA fiber-ZnO nanowire composites, 
whereas 15 µg of ZBP-CEA was saturated with the same amount of PLLA 
fibers when incubated them with 80 µg of the antigen for 1 h. Non-specific 




Figure 2-4. Immobilization of polypeptide on PLLA fiber-ZnO nanowire 
composites. (A) Microscopic image of fragmented PLLA fiber-ZnO nanowire 
composites coated with ZBP-labeled with FITC. Representative fluorescence 
(top) or differential interference contrast (bottom) images of the 
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nanocomposite fragments are presented. (B) Indicated amounts of ZBP-FITC 
were incubated with the composites (250 µg) at room temperature for 1 h, and 
the relative binding of ZBP-FITC was assessed by measuring the fluorescence 
intensity. a.u., arbitrary unit. The data are from three separate experiments. 
(C) Gel electrophoresis data showing the relative fraction of bound CEA 
antigen to PLLA fibers (PLLA) or PLLA fiber-ZnO nanowire composites 
(PLLA-ZnO). Bound CEA was resolved by sodium dodecyl sulphate 
polyacrylamide gel electrophoresis after incubation with the composites (250 
µg) and the indicated amounts of CEA. (D) Bound CEA amount from (C) 
















7.3.4. Intracellular antigen delivery by PLLA fiber-ZnO 
nanowire composites 
Next, I assessed the efficacy of intracellular delivery of the associated antigen 
into dendritic cells by using the composites, since I previously observed 
efficient delivery of biomacromolecules coated on the surface of radially 
grown ZnO nanowires into eukaryotic cells. As shown in Fig 2-5 A and B, 
most (> 90%) of the live cells collected after 30 min of incubation at 37°C on 
ZBP-FITC-coated PLLA fiber-ZnO nanowire composites were positive for 
FITC signal, and the fluorescence intensities were saturated thereafter, 
whereas only a fraction (~ 35%) of DC2.4 cells incubated with equal amount 
of PLLA fiber mixed with ZBP-FITC showed positive signals for FITC after 
30 min of incubation and the positive percentile was rapidly declined to ~ 
10% thereafter. 
 
7.3.5. Effect of PLLA fiber-ZnO nanowire composites on 
DC2.4 cell activation 
I measured inflammatory cytokines secreted by DC2.4 cells after stimulation 
with PLLA fiber-ZnO nanowire composites. Treatment of the nanocomposites 
induced significantly higher levels of inflammatory cytokines, such as IL-1β, 
IL-6, IL-10, and TNF-α when compare with untreated or PLLA fiber-treated 
cells, although the cytokine responses, except TNF-α, were generally lower in 
cells stimulated with LPS as a positive control (Fig. 2-6). Nevertheless, all the 
cytokine levels, except IL-1β, were further elevated in cell culture 
supernatants from cells treated with the PLLA fiber-ZnO nanowire 
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composites when compared to those from PLLA fiber-treated cells, 
suggesting that ZnO nanowires might be the primary stimulatory components 
to enhance the inflammatory responses in dendritic cells. 
To further confirm the cellular activation, the activation markers of 
dendritic cells were also examined after stimulation with the nanocomposites. 
The surface expression of the activation markers, CD40 and CD80, were 
significantly increased after stimulation with PLLA fiber-ZnO nanowire 
composites when compared to those of untreated cells (Fig. 2-7 A-B), 
whereas expression of MHC II and CD86 on the DC2.4 cells was only slightly 
increased without statistical significance (Fig. 2-7 B). None of the activation 
markers was significantly elevated in cells treated with PLLA fibers, 
suggesting again that ZnO nanowires might be primary stimulants for the 
cellular activation, even though the degree of activation was generally lower 

















Figure 2-5. Intracellular uptake of peptides coated on PLLA fiber ZnO 
nanowire composites by dendritic cells. 
DC2.4 cells were incubated with indicated complexes coated with ZBP-FITC 
at 37°C for the indicated times and analyzed by flow cytometry. (A) Live cells 
were gated based on a scatter plot, and fluorescence intensities of cells were 
assessed. Representative flow cytometric data and the kinetic changes of 
FITC-positive cellular fraction are presented. (B) Representative histograms 
of the indicated cell subset cultured with PLLA or PLLA-ZnO nano 
composite. The graphical representation of saturation percentage of 
fluorescein positive-stained cells at different time points. Diagrams show the 


















Figure 2-6. Pro-inflammatory response of dendritic cells cultured with 
PLLA fiber-ZnO nanowire composites. DC2.4 cells were incubated with 
the indicated complexes at 37°C for 18 h and inflammatory cytokines were 
measured in the culture supernatants (n = 4).  p < 0.05; **, p < 0.01; ***, p < 
0.001.  













Figure 2-7. Effect on surface expression of the co-stimulatory molecule in 
dendritic cells cultured with PLLA fiber-ZnO nanowire composites. 
Phenotypic changes of DC2.4 cells after stimulation with the indicated 
complexes were examined by staining for cellular surface markers. (A) The 
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surface expressions of the co-stimulatory molecules on DC2.4 cells were 
analyzed by flow cytometry. (B) The relative surface expression levels of 
indicated molecules in comparison with untreated cells (CNT) were presented 





















7.3.6. T cell responses induced by PLLA fiber-ZnO 
nanowire composites  
I directly immunized C57BL/6 mice with PLLA fiber-ZnO nanowire 
composites (1 mg/mouse) mixed with 100 µg of ZBP-CEA and analyzed 
CEA-specific cellular immunity. At two weeks after second immunization, I 
examined T-cell responses in splenocytes by measuring their production of 
IFN-γ, a hallmark cytokine for cell-mediated immunity, in an antigen-
dependent manner (Fig. 2-8 A). The frequencies of IFN-γ-secreting CD4 or 
CD8 T cells in spleens of mice immunized with the nanocomposites 
complexed with ZBP-CEA significantly increased, when compared to those of 
non-immunized controls (CNT and PLLA-ZnO) or mice immunized with 
PLLA fibers mixed with the same amount of ZBP-CEA antigens. It is notable 
that presence of ZnO nanowires in the complex significantly enhanced the 
antigen-specific T cells responses by approximately 70 ~ 100%. Furthermore, 
prominent cytotoxic responses against CEA-expressing cancer cells 
(MC38/CEA) were induced in mice immunized with the nanocomposites 
complexed with ZBP–CEA, whereas no significant cytotoxicity was detected 
in the control groups (Fig. 2-8 B), PLLA-ZnO only or untreated group [data 
not shown].  
 
7.3.7. Anti-cancer effect of PLLA fiber-ZnO nanowire 
composites 
To further prove the functional significance of CEA-specific adaptive 
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immunity generated in vivo for anti-cancer immunotherapy, mice inoculated 
with MC38/CEA cells were immunized three times with weekly intervals and 
the tumor growth was monitored for a month. As shown in Fig 2-8 C, tumor 
growth was significantly suppressed in mice immunized with PLLA fiber-
ZnO nanowire composites coated with ZBP–CEA and all of them survived, 
whereas other control groups failed to protect the mice during the observation 
period and all the mice were sacrificed due to the enlarged tumors. Since we 
observed mice immunized with PLLA fibers mixed with ZBP-CEA also 
showed significance rise of CEA-specific T cell responses, but failed to 
suppress the tumor growth. The systemic immunosuppression and the 
infiltration of T cells in growing tumors were assessed at day 24 after tumor 
inoculation in the immunized mice groups by analyzing the proportion of T 
cells in spleens and tumors, respectively (Fig. 2-9 and 2-10). Systemic 
reductions of T cells, as well as gradual increase in regulatory T cells (Treg) in 
tumor-bearing hosts, have been well established. In addition, immune 
contextures of growing tumors, especially tumor-infiltrating CTLs, have been 
shown to correlate with clinical outcomes [74]. In spleens of tumor-bearing 
mice, I observed drastic reduction of CD4 and CD8 T cells, generally less 




Figure 2-8. CEA-specific, IFN-γ-positive CD4 and CD8 T-cell responses 
of mice immunized with the indicated complexes. (A) IFN-γ-positive T 
cells in splenocytes were detected in the presence (+) or absence (–) of CEA. 
Top panels: representative dot plots. Bottom panels: average percentiles of the 
T cells from three independent experiments. (B) Cytotoxic activity of 
splenocytes from immunized mice. MC38 cells expressing CEA 
(MC38/CEA) were used as targets. (C) Tumor volume of mice (5 mice/group) 
injected with MC38/CEA cells. Mice were immunized three times with the 
indicated complexes at 7, 14, 21 days after tumor cell injection. Mice bearing 
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tumors over 2 cm3 at the day of observation were sacrificed humanely. 
Representative images of tumors collected from sacrificed mice (bottom 















Figure 2-9. Flow cytometry analysis of immune cells subsets in spleen of 
tumor bearing mice. Hematopoietic immune cells were quantitated in spleen 
at day 24 after tumor inoculation in the indicated mice groups. (A) Gating 
strategy for relative fraction of hematopoietic immune cells in spleen. (B) 
Relative fractions (n = 3) of hematopoietic immune cells (CD45+), CD4+, 
CD8+, and regulator T cells (Treg, CD4+/FoxP3+). CNT: non-immunized mice. 






Figure 2-10. Flow cytometry analysis of tumor infiltrating immune cells 
subsets in tumor tissues. (CD45+), CD4+, CD8+, and regulator T (Treg, 
CD4+/FoxP3+) cells were quantitated in tumor tissues at day 24 after tumor 
inoculation in the indicated mice groups (A) Representative flow cytometric 
plots showing progressive gating strategy for analysis of tumor infiltrating 
lymphocytes. (B) Relative fractions (n = 3) of tumor infiltrating immune 








It has been shown that ZnO nanowires can be grown as radial bundles from 
ZnO NPs which are dispersed in solution or coated outside of various kinds of 
substrates [83-84]. However, it is interesting to note that we can obtain similar 
morphology of ZnO nanowires to the previous reports even if the seed layer 
of ZnO NPs exist inside the PLLA fibers. The precursors dissolved in the 
aqueous solution such as Zn2+ and OH- may diffuse into PLLA fiber during 
the hydrothermal reaction, and the ZnO crystals can be gradually nucleated 
and grown as radial nanowires on the surface of ZnO NPs, potentially 
exposed on PLLA fibers, serving as seeds. The kinetic responses of cellular 
apoptosis induced by PLLA fiber-ZnO nanowire composites were slightly 
different from those observed in the previous study using ZnO nanowire 
arrays on glass coverslip. HEK293 cells grown on glass coverslips coated 
with ZnO nanowires showed early apoptotic phenotype peaked (~ 40%) at the 
earlier stage (~3 h) of exposure and late apoptosis were peaked (~ 35%) at 6 h 
of incubation. This might be due to the cell type differences (phagocytic 
dendritic cell vs. fibroblast) or the culture matrix (plastic culture plate vs. 
glass cover slip). Nevertheless, the degree of cellular apoptosis, but not 
necrosis, was significantly higher in both of the cell types, primarily due to 
ZnO nanowires, during the initial stage of incubation. Since cellular apoptosis 
was rapidly induced during the early phase of incubation with ZnO nanowires 
and gradually declined thereafter, cellular adaptation potentially helps to 
overcome apoptotic stress endowed by ZnO nanowires and cells can start to 
replicate even in the presence of the ZnO nanowire composites, as 
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consistently observed in our previous and current studies.  
To utilize PLLA fiber-ZnO nanowire composites as an antigen 
delivery system, we used a ZnO-binding peptide (ZBP) and examined its 
binding capacity to the nanocomposites. Approximately 22 µg of ZBP-CEA 
protein showed saturated binding to 250 µg of PLLA fiber-ZnO nanowire 
composites, whereas 15 µg of ZBP-CEA was saturated with the same amount 
of PLLA fibers when incubated them with 80 µg of the antigen for 1 h (Fig. 2-
4). Non-specific adsorption of a protein, ovalbumin, has also been reported 
previously [85]. Nevertheless, these results show that the tumor-associated 
protein antigen fused with ZBP could be immobilized more efficiently on the 
PLLA fiber-ZnO nanowire composites than unmodified PLLA fibers, 
primarily via enhanced affinity to ZnO nanowires endowed by conjugated 
ZBP [15, 18]. In addition, the larger surface area of ZnO nanowires may 
enhance the binding capacity of the nanocomposites over the naked PLLA 
fiber. Next, I accessed the efficacy of intracellular delivery of the associated 
antigen into dendritic cells by using the composites coated with FITC antigen, 
since in previous chapter efficient delivery of biomacromolecules coated on 
the surface of radially grown ZnO nanowires into eukaryotic cells was 
observed. A very high percentage (> 90%) of the live cells collected after 30 
min of incubation at 37°C on ZBP-FITC-coated PLLA fiber-ZnO nanowire 
composites were positive for FITC signal compared to PLLA fiber (Fig. 2-5 
A-B). These results indicate that the peptide molecules coated on the 
nanowires are efficiently and rapidly delivered into the antigen-presenting 
cells. Rapid saturation of the peptides also suggests that cells potentially 
uptake the peptide molecules coated on the tips of ZnO nanowires right after 
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cellular contact, as observed in the previous study. 
Since we and others consistently observed immunomodulatory and/or 
inflammatory effects of ZnO nanostructures on antigen-presenting phagocytic 
cells, including macrophages and dendritic cells [15, 21, 61, 66]. I measured 
inflammatory cytokines secreted by DC2.4 cells after stimulation with PLLA 
fiber-ZnO nanowire composites. A significantly higher level of inflammatory 
cytokines, such as IL-1β, IL-6, IL-10, and TNF-α was observed, although the 
cytokine responses, except TNF-α, were generally lower in cells stimulated 
with LPS as positive control (Fig. 2-6). However, these cytokine responses, 
except TNF- α, were generally lower in cells stimulated with LPS as positive 
control. Nevertheless, all the cytokine levels, except IL-1 β, were further 
elevated in cell culture supernatants from cells treated with the PLLA fiber – 
ZnO nanowires composites, when compared to those from PLLA fiber-treated 
cells, suggesting that ZnO nanowires might be the primary stimulatory 
components in enhancing inflammatory responses in dendritic cells. 
To further confirm cellular activation of dendritic cells, I examined activation 
markers after stimulation with the nanocomposites. The surface expression of 
the activation markers, CD40 and CD80, were significantly increased after 
stimulation with PLLA fiber-ZnO nanowire composites when compared to 
those of untreated cells (Fig. 2-7), while expression of MHC II and CD86 on 
the DC2.4 cells was only slightly increased without statistical significance 
(Fig. 2-7 A-B). None of the activation markers was significantly elevated in 
cells treated with PLLA fibers, suggesting that ZnO nanowires might be 
primary stimulants for the cellular activation, even though the degree of 
activation was generally lower than those stimulated with LPS. None of the 
83 
 
activation markers was significantly elevated in cells treated with PLLA 
fibers, suggesting again that ZnO nanowires might be primary stimulants for 
the cellular activation, even though the degree of activation was generally 
lower than those stimulated with LPS. These results demonstrate that PLLA 
fiber-ZnO nanowire composites can stimulate the antigen presenting 
phagocytes and induce inflammatory responses, primarily due to ZnO 
nanowire components. Significant induction of the inflammatory cytokines, as 
well as activation of dendritic cells, by PLLA fiber-ZnO nanowire 
composites, prompted me to examine potential applicability of the 
nanocomposites as an immune-adjuvant for cancer immunotherapy. T-cell 
responses in splenocytes by measuring their production of IFN-γ, a hallmark 
cytokine for cell-mediated immunity, in an antigen-dependent manner, were 
examined. The frequencies of IFN-γ-secreting CD4 or CD8 T cells in spleens 
of mice immunized with the nanocomposites complexed with ZBP-CEA 
significantly increased. It is notable that the presence of zno nanowires in the 
complex significantly enhanced the antigen-specific T cells responses by 
approximately 70 ~ 100%. Furthermore, prominent cytotoxic responses 
against CEA-expressing cancer cells (MC38/CEA) were induced in mice 
immunized with the nanocomposites complexed with ZBP–CEA, whereas no 
significant cytotoxicity was detected in the control groups (Fig. 2-8 B). Even 
though splenocytes from mice immunized with PLLA fiber mixed with ZBP-
CEA also enhanced the cytotoxic activity against the cancer cells expressing 
CEA, those from mice immunized with the nanocomposites coated with the 
cancer antigen always showed slightly better CTL activity, but without 
statistical significance (Fig. 2-8 B). To further prove the functional 
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significance of CEA-specific adaptive immunity generated in vivo for anti-
cancer immunotherapy, mice inoculated with MC38/CEA cells were 
immunized three times with weekly intervals and the tumor growth was 
monitored for a month. It was observed that tumor growth was significantly 
suppressed in mice immunized with PLLA fiber-ZnO nanowire composites 
coated with ZBP–CEA and all of them survived, whereas other control groups 
failed to protect the mice. Since we observed mice immunized with PLLA 
fibers mixed with ZBP-CEA also showed significance rise of CEA-specific T 
cell responses, but failed to suppress the tumor growth, systemic 
immunosuppression and the infiltration of T cells in growing tumors were 
assessed at day 24 after tumor inoculation in the immunized mice groups by 
analyzing the proportion of T cells in spleens and tumors, respectively (Fig. 2-
9 and 2-10). Systemic reduction of T cells, as well as a gradual increase in 
regulatory T cells (Treg) in tumor-bearing hosts, have been well established 
[66-68]. In addition, immune contextures of growing tumors, especially 
tumor-infiltrating CTLs, have been shown to correlate with clinical outcomes 
[63]. In spleens of tumor-bearing mice, I observed drastic reduction of CD4 
and CD8 T cells, generally less than 1 and 2 % among whole splenocytes, 
respectively (Fig. 2-9 and Fig. 2-10). In normal mice, CD4 and CD8 T cells 
generally occupy 20 and 10% among splenocytes, respectively [66], 
indicating that all the tumor-bearing mice suffered from systemic T cell 
suppression regardless of immunization. Nevertheless, mice immunized with 
PLLA fiber-ZnO nanowire composites complexed with ZBP-CEA retained 
significantly higher frequencies of CD4 T cells with lower Treg cell 
proportions in spleens than other control groups. Additionally, this mice group 
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showed significantly higher levels of tumor-infiltrating CD4 and CD8 T cells, 
despite of the similar degree of CD45+ immune cells and Treg cells in tumor 
tissues (Fig 2-10 A-B), suggesting better immune contexture in the tumor 
microenvironment than other control groups. These results suggest that 
inclusion of ZnO nanowires complexed with a tumor antigen in the 
therapeutic cancer vaccine formulation based on PLLA fiber matrix can 
enhance antigen-specific T cell responses and promotes their infiltration into 
tumors, thereby suppressing the tumor growth better than the complexes 
without ZnO nanowires. 
Biocompatible PLLA-based formula has shown immense potential as a drug 
delivery carrier and as scaffolds for various biomedical applications [70-71]. 
This organic material has been successfully applied to vaccine development 
for infectious diseases and cancers [28, 72-76]. However, recent studies also 
reported that a similar organic material, polylactic-co-glycolic acid (PLGA) 
particles, can also induce immune tolerance against the associated peptides for 
treatment of autoimmune diseases, depending on particle size, shape, 
composition, and route of administration [77-78]. It was shown that 
tolerogenic effects require PLGA microparticle uptake by macrophages 
expressing the scavenger receptor MARCO and are mediated in part by the 
activity of regulatory T cells, abortive T-cell activation and T-cell anergy 
[78]. In addition, inert PLLA itself may have an immune suppressive effect 
and/or promote tissue repair and foreign body reaction, enabling them to be 
used as scaffolds for tissue engineering [79-80]. Therefore, considerable 
modification of the composition and structure of the inert organic material 
might be critical for biomedical applications as a vaccine carrier and/or 
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adjuvant [76]. Incorporation of immune-stimulating agents, such as Toll-like 
receptor (TLR) ligands, into the formulation is one of promising ways for 
cancer vaccine development to boost adaptive immunity [76]. Here, we 
synthesized radially grown ZnO nanowires on PLLA microfibers with unique 
3-dimensional structure and applied for a therapeutic cancer vaccine. Similar 
hybrid composites, comprised of ZnO nanostructures and PLLA matrix, has 
been used for photocatalytic water purification, anti-bacterial agent, and 
cellular differentiation of myoblast [31-33, 81]. Nevertheless, this study is a 
first application of the novel hybrid nanocomposite as a vaccine adjuvant. 
This inorganic-organic hybrid nanocomposite has mild cellular toxicity and 
can efficiently stimulate innate APC, dendritic cell, to express inflammatory 
cytokines and activation surface markers. Induction of these innate immune 
responses may result from the direct recognition of ZNPs by Toll-like 
receptors (TLR4 or TLR6) or indirectly by intracellular ROS generation 
resulting from disrupted cellular zinc homeostasis [36, 59].  Induction of in 
vivo inflammation by ZnO nanowires was also reported previously [66]. In 
this study, I demonstrated that the hybrid nanocomposites could successfully 
induce a tumor antigen-specific cellular immunity and significantly inhibit 
tumor growth in vivo, potentially via efficient intracellular delivery of 
associated antigen into APCs as well as stimulation of innate immunity. 
Multifunctional interaction of ZnO nanostructures with the biological system 
may also enable them to be used as an attractive anticancer agent. Even 
though the mechanistic correlation of ZnO nanowires with systemic reduction 
of Treg and enhanced infiltration of T cells into tumor tissues need to be 
further defined in the future study, These current results open a new avenue to 
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extend the biomedical application of inorganic metal oxide-inert organic 
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산화아연(zinc oxide, ZnO) 나노복합체는 다양한 기능과 생체적합성 
때문에 의공학 분야에서 광범위하게 사용되고 있다. 그러나 산화아
연 나노복합체와 생물학적 시스템 또는 면역체계와의 상호작용 및 
그 물리, 화학적 특성은 아직 잘 밝혀지지 않았다. 산화아연 나노선
의 의학적 활용가능성을 알아보기 위하여, 본 연구에서는 산화아연 
나노선을 커버슬립 위에 수직 형태(vertical nanowire, VNW) 혹은 부
채꼴 형태(fan-shaped nanowire, FNW)로 코팅한 후, 그 위에 세포를 
배양하여 각각의 세포 활성도의 변화를 측정하였다. VNW 와 FNW 
산화아연 나노선에서 배양한 HEK293 세포는 배양 후 6시간까지 세
포사멸이 증가하였지만, 그 후 12시간까지는 유의할 만한 세포사멸
을 보이지 않으며 생존하였다. FNW에서 자란 세포는 표면을 감싸는 
층상위족(lamellipodia)을 형성하였고, 나노선에 결합된 ZBP-FITC를 
30분내에 효과적으로 세포내로 섭취하였다. 또한,  FNW에 결합한 
DNA를 세포 내로 전달하고 세포에서 단백질로 발현되는 것을 확인
함으로써, FNW에 의해 외부의 DNA를 핵 내부로 전달할 수 있음을 
증명하였다. 이 결과로, 산화아연 나노선 배열이 적절한 3차원 구조
를 가진다면 효과적인 나노-바이오 결합체로써 작용할 수 있음을 알 
수 있었다. 그에 따라, 폴리젖산 미세섬유에 산화아연 나노선을 방
사형으로 자라나게 한 독특한 3차원 구조물을 합성하였고, 치료용 
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암 백신으로써 산화아연 나노복합체의 항-종양 면역능을 검증하였다.  
이 무기물-유기물 하이브리드 나노복합체는 낮은 세포독성을 띠며, 
결합된 종양 항원을 효과적으로 수지상세포 안으로 전달하고 세포
가 염증성 사이토카인을 발현하게 하여, 선천면역과 적응면역을 연
결하는 역할을 하는 것으로 관찰되었다. 이 복합체는 항원-특이적 
세포 면역을 효과적으로 유도하며, 종양의 성장을 유의하게 억제하
였다. 생체 전반적인 조절 T 세포가 감소하고 종양 조직으로 T 세
포의 유입이 증가하였다. 무기물-유기물 하이브리드 나노복합체를 
활용하여 항암면역치료에 적용함으로써 새로운 백신 플랫폼으로의 
가능성을 보였다.  
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